With its advanced immunoassay technology and optimized testing protocols, the fully automated VIDAS^® 3 benchtop immunoanalyzer empowers your lab with confidence, offering the precise results you need, when you need them. 

VIDAS^® KUBE™ is designed to preserve everything labs appreciate about the VIDAS^® Solution combined with advanced technology. VIDAS^® KUBE™ is a truly flexible, cost-effective automated immunoassay solution providing fast results in complete confidence.

Our VIDAS^® Anemia assays provide a comprehensive solution for diagnosing multiple causes of anemia, including iron deficiency, vitamin B12 deficiency and anemia related to chronic diseases.

Our VIDAS^® offer of immunoassays directed against arboviruses diseases improve access to medically important automated diagnostic tests. 

Detects procalcitonin, a biomarker that aids in the risk assessment for progression to severe sepsis and septic shock. PCT also aids in decision making on antibiotic therapy for patients with lower respiratory tract infections (LRTI).

An easy access to innovative cardiac tests for acute and complex situations to deliver reliable, fast, and actionable results to clinicians. bioMérieux with VIDAS^® provides a comprehensive emergency & critical care offer for better patient with cardiovascular disease management in the emergency department.

The VIDAS^® C. difficile Panel includes two complementary tests that aid in the diagnosis of C. difficile infection. 

VIDAS^® D-Dimer Exclusion™ II is a highly-sensitive automated D-Dimer assay. Used in conjunction with assessment of clinical pretest probability, it allows safe exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE) in both low and intermediate suspected outpatient risk groups in just 20 minutes.

The VIDAS^® Hepatitis panel includes 11 markers for the diagnosis of recent infection, monitoring of chronic hepatitis, pre- or post-vaccination immunity controls and screening during pregnancy.

The VIDAS^® High sensitive Troponin I assay is intended to be used as an aid in the diagnosis of myocardial infarction delivering actionable results in only 2 hours and for the risk stratification of adult patients with acute coronary syndrome.

VIDAS^® NEPHROCHECK^® is an automated test for use on the VIDAS^® 3 instrument for the immunoenzymatic quantitative determination of TIMP-2 (Tissue Inhibitor of Metalloproteinase-2) and IGFBP-7 (Insulin-like Growth Factor-Binding Protein 7) proteins in human urine using the ELFA technique (Enzyme Linked Fluorescent Assay).

The VIDAS^® NEPHROCHECK^® assay is intended to be used in conjunction with clinical evaluation as an aid in the risk assessment for moderate or severe acute kidney injury (AKI) in acutely ill patients.

VIDAS^® NT-proBNP2 is a useful tool for rapid and clinical assessment and diagnosis of patients with symptoms of suspected heart failure.

High sensitivity and specificity allows initiation of timely, appropriate treatment.

Cost-effective tool adapted to emergency situations.

VIDAS^® SARS-COV-2 IgM and VIDAS^® SARS-COV-2 IgG II automated assays rapidly detect antibodies to help identify individuals with previous exposure to SARS-CoV-2.

Fast all-in-one test kit based on blood-based brain biomarkers to predict absence of intracranial lesions in mild Traumatic Brain Injury patients and objectively assess the need for a head CT-scan.

Available on the VIDAS^® 3 immunoanalyzer, VIDAS^® TB-IGRA is an aid in the diagnosis of Mycobacterium tuberculosis infection.

The VIDAS^® ToRC panel includes 9 automated tests for the screening and diagnosis of toxoplasmosis, rubella, and cytomegalovirus (CMV) infections.

Designed for healthcare professionals, MYACUTECASE™ is a first-of-its-kind app. Used in conjunction with clinical assessment and other laboratory findings, it provides comprehensive biomarker information and useful tools for: